Patient care at Weill Cornell Medicine has not been materially impacted by a technology outage. READ MORE HERE

Robert Forman Spiera, M.D.


Locations and Appointments

Insurances Accepted

For relevant information regarding accepted insurances, please contact this provider directly.

Biographical Info

Dr. Robert Spiera is the Director of the Vasculitis and Scleroderma Program at the Hospital for Special Surgery. He is the principal investigator in several clinical trials and observational studies focusing on Scleroderma and Vasculitis. Dr. Spiera specializes in the treatment of various rheumatologic conditions including Scleroderma, Vasculitis, Systemic Lupus Erythematosus, Wegener’s Granulomatosis, Rheumatoid Arthritis, and many other conditions. He has authored over 70 publications relating to Scleroderma, Vasculitis, and other rheumatic diseases.


Honors and Awards

Rheumatology Teacher of the Year – Emmanuel Rudd, M.D. and Martin Gardy, M.D. Best Rheumatology Fellow Teacher Award, 2006

Founders Award Recipient for Clinical Investigation – Scleroderma Foundation, 2005

The Globus Award (The outstanding article in Mount Sinai Journal of Medicine in 1997) – The Mount Sinai School of Medicine, 1998



Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Rheumatology)
Clinical Expertise
Inflammatory Arthritis
SLE (Systemic Lupus Erythematosus)
Rheumatoid Arthritis
Sjogren's Syndrome
Rheumatic Disease
  • M.D.
    Yale University School of Medicine
  • Attending Physician
    Hospital for Special Surgery
  • Attending Physician
    NewYork-Presbyterian Hospital
  • Professor of Clinical Medicine
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported